Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monoamine Antagonist Therapies for Methamphetamine Abuse Prazosin

NCT01178138 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.

NCT NCT01178138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01178138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monoamine Antagonist Therapies for Methamphetamine Abuse Prazosin
Lead sponsor
University of Arkansas
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2009
Completion date
June 30, 2013
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

continuous methamphetamine abuse